Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : AJANTPHARMBSE : 532331ISIN CODE : INE031B01049Industry : Pharmaceuticals & DrugsHouse : Vimal Agrawal

BSE2786.3085.9 (+3.18 %)

PREV CLOSE ( ) 2700.40

OPEN PRICE ( ) 2707.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 14973

TODAY'S LOW / HIGH ( )2690.00 2796.80

52 WK LOW / HIGH ( )2022.05 3485.75

NSE2787.8090.1 (+3.34 %)

PREV CLOSE( ) 2697.70

OPEN PRICE ( ) 2710.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 2787.80 (101)

VOLUME 286047

TODAY'S LOW / HIGH( ) 2687.00 2794.00

52 WK LOW / HIGH ( )2223.55 3485

Chairman	Mannalal B Agrawal
Managing Director	Yogesh M Agrawal
Company Secretary	Gaurang Shah
Vice Chairman	Madhusudan B Agrawal
Joint Managing Director	Rajesh M Agrawal
Non Executive Independent Director	David Rasquinha Medha Joshi Rajesh Dalal Simi Thapar

Incorporation Year : 31-12 1979

Registered Office :

Address : Ajanta House,Charkop ,Kandivali (West) Mumbai,
Maharashtra-400067 .

Phone : 022-60609000 / 66061000

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE